Ajax loader
By using our website, you agree to our use of cookies as described in Cookie Policy.

Can't find what you're looking for?

 

Be sure to Sign in to see all available content.

 

If you don't have an account, Register here.

Search results for: Scientific-equipment

HEALTH-CORONAVIRUS/USA-BIOTECH
RTX7RINV
August 24, 2020
Nathan Arant, co-owner of bio-tech company New Life Scientific, searches for lab equipment products to...
CRIDERSVILLE, UNITED STATES
Visit to bio-tech company New Life Scientific
Nathan Arant, co-owner of bio-tech company New Life Scientific, searches for lab equipment products to buy as equipment that tests for the coronavirus disease (COVID-19) is in high demand, in Cridersville, Ohio, U.S., August 24, 2020. REUTERS/Seth Herald
HEALTH-CORONAVIRUS/USA-BIOTECH
RTX7RINL
August 24, 2020
Rich Lavy, owner of bio-tech company New Life Scientific, is seen at his office on the workshop floor,...
CRIDERSVILLE, UNITED STATES
Visit to bio-tech company New Life Scientific
Rich Lavy, owner of bio-tech company New Life Scientific, is seen at his office on the workshop floor, which rebuilds and sells used equipment, some of which are used for the coronavirus disease (COVID-19) testing, in Cridersville, Ohio, U.S., August 24, 2020. REUTERS/Seth Herald
HEALTH-CORONAVIRUS/USA-BIOTECH
RTX7RIMO
August 24, 2020
Steve Frueh runs a diagnostic test on a PerkinElmer LAMBDA 25, which is used for the coronavirus disease...
CRIDERSVILLE, UNITED STATES
Visit to bio-tech company New Life Scientific
Steve Frueh runs a diagnostic test on a PerkinElmer LAMBDA 25, which is used for the coronavirus disease (COVID-19) testing, at the bio-tech company New Life Scientific in Cridersville, Ohio, U.S., August 24, 2020. REUTERS/Seth Herald REFILE - CORRECTING SPELLING OF EQUIPMENT BRAND
HEALTH-CORONAVIRUS/USA-BIOTECH
RTX7RIMN
August 24, 2020
An exterior view of the bio-tech company New Life Scientific that resells used lab equipment, some of...
CRIDERSVILLE, UNITED STATES
Visit to bio-tech company New Life Scientific
An exterior view of the bio-tech company New Life Scientific that resells used lab equipment, some of which are used for the coronavirus disease (COVID-19) testing, in Cridersville, Ohio, U.S., August 24, 2020. REUTERS/Seth Herald
CORONA-VIRUS/
RTS300G7
January 29, 2020
Test tube with Corona virus name label is seen in this illustration taken on January 29, 2020. REUTERS/Dado...
Sarajevo, Bosnia and Herzegovina
Test tube with Corona virus name label is seen in this illustration picture
Test tube with Corona virus name label is seen in this illustration taken on January 29, 2020. REUTERS/Dado Ruvic
CORONA-VIRUS/
RTS300G0
January 29, 2020
Test tube with Corona virus name label is seen in this illustration taken on January 29, 2020. REUTERS/Dado...
Sarajevo, Bosnia and Herzegovina
Test tube with Corona virus name label is seen in this illustration picture
Test tube with Corona virus name label is seen in this illustration taken on January 29, 2020. REUTERS/Dado Ruvic
CORONA-VIRUS/
RTS300FZ
January 29, 2020
Test tube with Corona virus name label is seen in this illustration taken on January 29, 2020. REUTERS/Dado...
Sarajevo, Bosnia and Herzegovina
Test tube with Corona virus name label is seen in this illustration picture
Test tube with Corona virus name label is seen in this illustration taken on January 29, 2020. REUTERS/Dado Ruvic
CORONA-VIRUS/
RTS300FY
January 29, 2020
Test tube with Corona virus name label is seen in this illustration taken on January 29, 2020. REUTERS/Dado...
Sarajevo, Bosnia and Herzegovina
Test tube with Corona virus name label is seen in this illustration picture
Test tube with Corona virus name label is seen in this illustration taken on January 29, 2020. REUTERS/Dado Ruvic
BRITAIN-ECONOMY/GDP
RTX6V5QJ
May 10, 2019
Britain's Chancellor of the Exchequer Philip Hammond chats with Ian Chapman, Chief Executive of the UK...
Oxford, United Kingdom
Britain's Chancellor Hammond marks the publication of the UK GDP first quarterly estimate during a visit...
Britain's Chancellor of the Exchequer Philip Hammond chats with Ian Chapman, Chief Executive of the UK Atomic Energy Authority, in front of nuclear fusion scientific equipment, as he marks the publication of the UK gross domestic product (GDP) first quarterly estimate during a visit to the Culham Science Centre in Abingdon, Oxfordshire, Britain May 10, 2019. Ben Birchall/Pool via REUTERS
BRITAIN-ECONOMY/GDP
RTX6V5QH
May 10, 2019
Britain's Chancellor of the Exchequer Philip Hammond listens to Ian Chapman, Chief Executive of the UK...
Oxford, United Kingdom
Britain's Chancellor Hammond marks the publication of the UK GDP first quarterly estimate during a visit...
Britain's Chancellor of the Exchequer Philip Hammond listens to Ian Chapman, Chief Executive of the UK Atomic Energy Authority, in front of nuclear fusion scientific equipment, as he marks the publication of the UK gross domestic product (GDP) first quarterly estimate during a visit to the Culham Science Centre in Abingdon, Oxfordshire, Britain May 10, 2019. Ben Birchall/Pool via REUTERS
BRITAIN-ECONOMY/GDP
RTX6V5QE
May 10, 2019
Britain's Chancellor of the Exchequer Philip Hammond listens to Ian Chapman, Chief Executive of the UK...
Oxford, United Kingdom
Britain's Chancellor Hammond marks the publication of the UK GDP first quarterly estimate during a visit...
Britain's Chancellor of the Exchequer Philip Hammond listens to Ian Chapman, Chief Executive of the UK Atomic Energy Authority, in front of nuclear fusion scientific equipment, as he marks the publication of the UK gross domestic product (GDP) first quarterly estimate during a visit to the Culham Science Centre in Abingdon, Oxfordshire, Britain May 10, 2019. Ben Birchall/Pool via REUTERS
CHINA-PETCLONING/
RTX6IWHT
December 17, 2018
A screen displays the microscopic image of an attempt to inseminate a dog egg at a lab of the biotech...
Beijing, China
Screen displays the microscopic image of an attempt to inseminate a dog egg at a lab of the biotech company...
A screen displays the microscopic image of an attempt to inseminate a dog egg at a lab of the biotech company Sinogene that specialises in dog cloning in Beijing, China June 15, 2018. Picture taken June 15, 2018. REUTERS/Thomas Peter
PORTUGAL-MARIJUANA/
RTX47IP7
January 10, 2018
Cannabis pipes are displayed at Triparte shop in downtown Lisbon, Portugal January 10, 2018. REUTERS/Rafael...
Lisbon, Portugal
Cannabis pipes are displayed at Triparte shop in downtown Lisbon
Cannabis pipes are displayed at Triparte shop in downtown Lisbon, Portugal January 10, 2018. REUTERS/Rafael Marchante
SINGAPORE-ANTS/
RTX38GCZ
May 31, 2017
A woman checks her test tube after catching a queen ant at a public housing estate in Singapore, May...
Singapore, Singapore
The Wider Image: Ant-hunting we will go!
A woman checks her test tube after catching a queen ant at a public housing estate in Singapore, May 3, 2017. REUTERS/Edgar Su SEARCH "SU ANTS" FOR THIS STORY. SEARCH "WIDER IMAGE" FOR ALL STORIES.
HEALTH-ZIKA/VACCINES
RTSQMK1
October 04, 2016
Lead Protein Production and Centrifugation scientist Paul Koelle operates a centrifuge control panel...
MERIDEN, UNITED STATES
Lead Protein Production and Centrifugation scientist Paul Koelle operates a centrifuge control panel...
Lead Protein Production and Centrifugation scientist Paul Koelle operates a centrifuge control panel where they are working on developing a vaccine for the Zika virus based on production of recombinant variations of the E protein from the Zika virus at the Protein Sciences Inc. headquarters in Meriden, Connecticut, U.S., June 20, 2016. Picture taken June 20, 2016. REUTERS/Mike Segar
HEALTH-ZIKA/VACCINES
RTSQMK0
October 04, 2016
Lead Protein Production and Centrifugation scientist Paul Koelle operates a centrifuge control panel...
MERIDEN, UNITED STATES
Lead Protein Production and Centrifugation scientist Paul Koelle operates a centrifuge control panel...
Lead Protein Production and Centrifugation scientist Paul Koelle operates a centrifuge control panel where they are working on developing a vaccine for the Zika virus based on production of recombinant variations of the E protein from the Zika virus at the Protein Sciences Inc. headquarters in Meriden, Connecticut, June 20, 2016. Picture taken June 20, 2016. REUTERS/Mike Segar
HEALTH-ZIKA/VACCINES
RTSQMJZ
October 04, 2016
Research scientist Dan Galperin works on Purified Recombinant Zika Enveloped Protein in his laboratory...
MERIDEN, UNITED STATES
Research scientist Dan Galperin works in the research labaratory at Protein Sciences Inc. where they...
Research scientist Dan Galperin works on Purified Recombinant Zika Enveloped Protein in his laboratory where they are working on developing a vaccine for the Zika virus based on production of recombinant variations of the E protein from the Zika virus at the Protein Sciences Inc. headquarters in Meriden, Connecticut, U.S., June 20, 2016. Picture taken June 20, 2016. REUTERS/Mike Segar
HEALTH-ZIKA/VACCINES
RTSQMJY
October 04, 2016
Research scientist Dan Galperin works on Purified Recombinant Zika Enveloped Protein in his laboratory...
MERIDEN, UNITED STATES
Research scientist Dan Galperin works in the research labaratory at Protein Sciences Inc. where they...
Research scientist Dan Galperin works on Purified Recombinant Zika Enveloped Protein in his laboratory where they are working on developing a vaccine for the Zika virus based on production of recombinant variations of the E protein from the Zika virus at the Protein Sciences Inc. headquarters in Meriden, Connecticut, U.S., June 20, 2016. Picture taken June 20, 2016. REUTERS/Mike Segar
HEALTH-ZIKA/VACCINES
RTSQMJW
October 04, 2016
Research scientist Dan Galperin works on Purified Recombinant Zika Enveloped Protein at his laboratory...
MERIDEN, UNITED STATES
Research scientist Dan Galperin works in the research labaratory at Protein Sciences Inc. where they...
Research scientist Dan Galperin works on Purified Recombinant Zika Enveloped Protein at his laboratory where they are working on developing a vaccine for the Zika virus based on production of recombinant variations of the E protein from the Zika virus at the Protein Sciences Inc. headquarters in Meriden, Connecticut, U.S., June 20, 2016. Picture taken June 20, 2016. REUTERS/Mike Segar
HEALTH-ZIKA/VACCINES
RTSQMJV
October 04, 2016
Research scientist Dan Galperin works on Purified Recombinant Zika Enveloped Protein in his laboratory...
MERIDEN, UNITED STATES
Research scientist Dan Galperin works in the research labaratory at Protein Sciences Inc. where they...
Research scientist Dan Galperin works on Purified Recombinant Zika Enveloped Protein in his laboratory where they are working on developing a vaccine for the Zika virus based on production of recombinant variations of the E protein from the Zika virus at the Protein Sciences Inc. headquarters in Meriden, Connecticut, U.S., June 20, 2016. Picture taken June 20, 2016. REUTERS/Mike Segar
HEALTH-ZIKA/VACCINES
RTSQMJU
October 04, 2016
Manufacturing Associate Theodore Szmurlo transfers a cell sample to a microscope slide as he works in...
MERIDEN, UNITED STATES
Manufacturing Associate Theodore Szmurlo transfers a cell sample to a microscope slide as he works in...
Manufacturing Associate Theodore Szmurlo transfers a cell sample to a microscope slide as he works in the cell culture room where they are working on developing a vaccine for the Zika virus based on production of recombinant variations of the E protein from the Zika virus at the Protein Sciences Inc. headquarters in Meriden, Connecticut, U.S., June 20, 2016. Picture taken June 20, 2016. REUTERS/Mike Segar
HEALTH-ZIKA/VACCINES
RTSQMJS
October 04, 2016
Manufacturing Associates Theodore Szmurlo (L) and David Artus work in a cell culture room where they...
MERIDEN, UNITED STATES
Manufacturing Associates Theodore Szmurlo and David Artus work in the cell culture room during work on...
Manufacturing Associates Theodore Szmurlo (L) and David Artus work in a cell culture room where they are working on developing a vaccine for the Zika virus based on production of recombinant variations of the E protein from the Zika virus at the Protein Sciences Inc. headquarters in Meriden, Connecticut, U.S., June 20, 2016. Picture taken June 20, 2016. REUTERS/Mike Segar
HEALTH-ZIKA/VACCINES
RTSQMJP
October 04, 2016
Manufacturing Associate Theodore Szmurlo views a cell sample with a microscope as he works in the cell...
MERIDEN, UNITED STATES
Manufacturing Associate Theodore Szmurlo views a cell sample on microscope as he works in the cell culture...
Manufacturing Associate Theodore Szmurlo views a cell sample with a microscope as he works in the cell culture room where they are working on developing a vaccine for the Zika virus based on production of recombinant variations of the E protein from the Zika virus at the Protein Sciences Inc. headquarters in Meriden, Connecticut, U.S., June 20, 2016. Picture taken June 20, 2016. REUTERS/Mike Segar
HEALTH-ZIKA/VACCINES
RTSQMJO
October 04, 2016
Manufacturing Associates Theodore Szmurlo and David Artus work in the cell culture room where they are...
MERIDEN, UNITED STATES
Manufacturing Associates Theodore Szmurlo and David Artus work in the cell culture room during work on...
Manufacturing Associates Theodore Szmurlo and David Artus work in the cell culture room where they are working on developing a vaccine for the Zika virus based on production of recombinant variations of the E protein from the Zika virus at the Protein Sciences Inc. headquarters in Meriden, Connecticut, U.S., June 20, 2016. Picture taken June 20, 2016. REUTERS/Mike Segar
HEALTH-ZIKA/VACCINES
RTSQMJM
October 04, 2016
Lead Protein Production and Centrifugation scientist Paul Koelle looks into a large bio reactor where...
MERIDEN, UNITED STATES
Lead Protein Production and Centrifugation scientist Paul Koelle looks into a large bio reactor at Protein...
Lead Protein Production and Centrifugation scientist Paul Koelle looks into a large bio reactor where they are working on developing a vaccine for the Zika virus based on production of recombinant variations of the E protein from the Zika virus at the Protein Sciences Inc. headquarters in Meriden, Connecticut, U.S., June 20, 2016. Picture taken June 20, 2016. REUTERS/Mike Segar
HEALTH-ZIKA/VACCINES
RTSQMJI
October 04, 2016
Research scientist Dan Galperin uses a dropper during his work on Purified Recombinant Zika Enveloped...
MERIDEN, UNITED STATES
Research scientist Dan Galperin holds files marked "Zika" at Protein Sciences Inc. where they are working...
Research scientist Dan Galperin uses a dropper during his work on Purified Recombinant Zika Enveloped Protein at the research laboratory where they are working on developing a vaccine for the Zika virus based on production of recombinant variations of the E protein from the Zika virus at the Protein Sciences Inc. headquarters in Meriden, Connecticut, U.S., June 20, 2016. Picture taken June 20, 2016. REUTERS/Mike Segar
HEALTH-ZIKA/VACCINES
RTSQMJG
October 04, 2016
Research scientist Dan Galperin holds vials marked "Zika" during his work on Purified Recombinant Zika...
MERIDEN, UNITED STATES
Research scientist Dan Galperin holds vials marked "Zika" at Protein Sciences Inc. where they are working...
Research scientist Dan Galperin holds vials marked "Zika" during his work on Purified Recombinant Zika Enveloped Protein at the research laboratory where they are working on developing a vaccine for the Zika virus based on production of recombinant variations of the E protein from the Zika virus at the Protein Sciences Inc. headquarters in Meriden, Connecticut, U.S., June 20, 2016. Picture taken June 20, 2016. REUTERS/Mike Segar
BRITAIN-ROYALS/
RTSHVXF
July 14, 2016
Prince Harry looks through a microscope at a sample of gonorrhoea as he visits the Burrell Street Sexual...
London, United Kingdom
Prince Harry looks through a microscope at a sample of gonorrhoea as he visits the Burrell Street Sexual...
Prince Harry looks through a microscope at a sample of gonorrhoea as he visits the Burrell Street Sexual Health Clinic in London, Britain on July 14, 2016. REUTERS/Chris Jackson/Pool
PHILIPPINES-POLICE/
RTX2GO7K
June 16, 2016
Laboratory equipment used in the productions of methamphetamine hydrochloride or Shabu is seen during...
Manila, Philippines
The Wider Image: On patrol with Manila's police
Laboratory equipment used in the productions of methamphetamine hydrochloride or Shabu is seen during a Philippine Drug Enforcement Agency destruction of chemicals and other evidence in Valenzuela city, north of Manila, Philippines May 24, 2016. REUTERS/Romeo Ranoco SEARCH "MANILA POLICE" FOR THIS STORY. SEARCH "THE WIDER IMAGE" FOR ALL STORIES
HEALTH-ZIKA/BRAZIL
RTX26K4I
February 11, 2016
A biologist works with Aedes mosquito cells in the laboratory of Biology from University of Campinas...
Campinas, Brazil
A biologist works with Aedes mosquito cells in the laboratory of Biology from University of Campinas...
A biologist works with Aedes mosquito cells in the laboratory of Biology from University of Campinas (UNICAMP), in Campinas, Brazil, February 11, 2016. According to UNICAMP, its scientists are developing a test to detect and identify the presence of genetic material associated with the Zika virus, dengue and Chikungunya in samples saliva, blood or urine. REUTERS/Paulo Whitaker
HEALTH-ZIKA/BRAZIL
RTX26K4B
February 11, 2016
Aedes mosquito cells inoculated with Zika virus are seen through a microscope in the laboratory of Biology...
Campinas, Brazil
Aedes mosquito cells inoculated with Zika virus are seen through a microscope in the laboratory of Biology...
Aedes mosquito cells inoculated with Zika virus are seen through a microscope in the laboratory of Biology from University of Campinas (UNICAMP), in Campinas, Brazil, February 11, 2016. According to UNICAMP, its scientists are developing a test to detect and identify the presence of genetic material associated with the Zika virus, dengue and Chikungunya in samples saliva, blood or urine. REUTERS/Paulo Whitaker
HEALTH-ZIKA/BRAZIL
RTX26K48
February 11, 2016
A biologist works with cell of Aedes mosquito in the laboratory of Biology from University of Campinas...
Campinas, Brazil
A biologist works with cell of Aedes mosquito in the laboratory of Biology from University of Campinas...
A biologist works with cell of Aedes mosquito in the laboratory of Biology from University of Campinas (UNICAMP), in Campinas, Brazil, February 11, 2016. According to UNICAMP, its scientists are developing a test to detect and identify the presence of genetic material associated with the Zika virus, dengue and Chikungunya in samples saliva, blood or urine. REUTERS/Paulo Whitaker
HEALTH-ZIKA-IAEA/
RTX26C1S
February 10, 2016
A scientist displays Aedes aegypti mosquitoes inside the International Atomic Energy Agency's (IAEA)...
SEIBERSDORF, Austria
A scientist displays Aedes aegypti mosquitoes inside the IAEA laboratory in Seibersdorf
A scientist displays Aedes aegypti mosquitoes inside the International Atomic Energy Agency's (IAEA) insect pest control laboratory in Seibersdorf, Austria, February 10, 2016. REUTERS/Leonhard Foeger TPX IMAGES OF THE DAY
HEALTH-ZIKA/GUATEMALA
RTX256J2
February 02, 2016
A municipal health worker shows off a test tube with larvae of Zika virus vector, the Aedes aegypti mosquito,...
Guatemala City, Guatemala
Municipal health worker shows off a test tube with larvae of Zika virus vector, the Aedes aegypti mosquito,...
A municipal health worker shows off a test tube with larvae of Zika virus vector, the Aedes aegypti mosquito, as part of the city's efforts to prevent the spread of the Zika, in Guatemala City, Guatemala, February 2, 2016. REUTERS/Josue Decavele
HEALTH-ZIKA/COSTA RICA
RTX24BH2
January 28, 2016
A health technician inspects blood sample from a patient infected by the bite of an Aedes aegypti mosquito...
San Jose, Costa Rica
A health technician inspects blood sample from a patient infected by the bite of an Aedes aegypti mosquito...
A health technician inspects blood sample from a patient infected by the bite of an Aedes aegypti mosquito through a microscope at Costa Rican Institute for Research and Teaching in Nutrition and Health (INCIENSA) in Tres Rios, Costa Rica January 27, 2016. The Health Ministry confirmed Tuesday the first case of the Zika virus in the country, according to local media. REUTERS/Juan Carlos Ulate
HEALTH-ZIKA/COSTA RICA
RTX24BEI
January 28, 2016
The cultivated eggs of Aedes aegypti mosquitoes is seen through a microscope inside a laboratory in the...
San Jose, Costa Rica
The cultivated eggs of Aedes aegypti mosquitoes is seen through a microscope inside a laboratory in the...
The cultivated eggs of Aedes aegypti mosquitoes is seen through a microscope inside a laboratory in the Ministry of Health in San Jose, Costa Rica January 27, 2016. The Health Ministry confirmed on Tuesday the first case of the Zika virus in the country, according to local media. REUTERS/Juan Carlos Ulate
HEALTH-ZIKA/COSTA RICA
RTX24BD9
January 28, 2016
A health technician inspects cultivated Aedes aegypti mosquito larvae through a microscope at a laboratory...
San Jose, Costa Rica
A health technician inspects cultivated Aedes aegypti mosquito larvae through a microscope at a laboratory...
A health technician inspects cultivated Aedes aegypti mosquito larvae through a microscope at a laboratory in the Ministry of Health in San Jose, Costa Rica January 27, 2016. The Health Ministry confirmed on Tuesday the first case of the Zika virus in the country, according to local media. REUTERS/Juan Carlos Ulate
HEALTH-ZIKA/BRAZIL
RTX24AN7
January 27, 2016
A technician of Oswaldo Cruz Foundation (Fiocruz) inspects an Aedes aegypti mosquito through a microscope...
Recife, Brazil
A technician of Oswaldo Cruz Foundation (Fiocruz) inspects an Aedes aegypti mosquito through a microscope...
A technician of Oswaldo Cruz Foundation (Fiocruz) inspects an Aedes aegypti mosquito through a microscope inside of a laboratory in Recife, Brazil, January 27, 2016. Health authorities in the Brazilian state at the center of a rapidly spreading Zika outbreak have been overwhelmed by the alarming surge in cases of babies born with microcephaly, a neurological disorder associated to the mosquito-borne virus. REUTERS/Ueslei Marcelino TPX IMAGES OF THE DAY
CHILE-SCIENCE/
RTX232AS
January 19, 2016
Chile's President Michelle Bachelet looks through a microscope during the opening ceremony of the Congress...
Santiago, Chile
Chile's President Bachelet looks through a microscope during the opening ceremony of the Congress of...
Chile's President Michelle Bachelet looks through a microscope during the opening ceremony of the Congress of the Future event in Santiago, Chile, January 19, 2016. REUTERS/Ivan Alvarado
MEXICO-ODDLY/
RTX1T0LL
October 24, 2015
REFILE - REMOVING EXTRANEOUS WORD Residents gather to observe the sky with telescopes while attending...
Ciudad Juarez, Mexico
Residents gather to observe the sky with telescopes while attending an open-air astronomy class in the...
REFILE - REMOVING EXTRANEOUS WORD Residents gather to observe the sky with telescopes while attending an open-air astronomy class in the Samalayuca Desert, on the outskirts of Ciudad Juarez, Mexico, October 23, 2015. Locals broke the Guinness record with the largest number of participants in an astronomy lesson with 1168 people assisting, breaking the previous record held by Shire of Kalamunda in Australia with 1104 participants, according to local media. Picture taken October 23, 2015. REUTERS/Jose Luis Gonzalez TPX IMAGES OF THE DAY
NOBEL-PRIZE/MEDICINE
RTS332C
October 05, 2015
William C. Campbell, a parasitologist and RISE Associate with Drew University, poses near a collection...
NORTH ANDOVER, UNITED STATES
William C. Campbell reacts shortly after learning that he was a co-winner of the Nobel Prize for Medicine,...
William C. Campbell, a parasitologist and RISE Associate with Drew University, poses near a collection of microscopes shortly after learning that he was a co-winner of the Nobel Prize for Medicine, at his home in North Andover, Massachusetts October 5, 2015. Three scientists from Japan, China and Ireland whose discoveries led to the development of potent new drugs against parasitic diseases such as malaria and elephantiasis won the Nobel Prize for Medicine on Monday. Irish-born William Campbell and Japan's Satoshi Omura won half of the prize for discovering avermectin, a derivative of which has been used to treat hundreds of millions of people with river blindness and lymphatic filariasis, or elephantiasis. REUTERS/Brian Snyder
NOBEL-PRIZE/MEDICINE
RTS331R
October 05, 2015
William C. Campbell, a parasitologist and RISE Associate with Drew University, views a collection of...
NORTH ANDOVER, UNITED STATES
William C. Campbell reacts shortly after learning that he was a co-winner of the Nobel Prize for Medicine,...
William C. Campbell, a parasitologist and RISE Associate with Drew University, views a collection of microscopes shortly after learning that he was a co-winner of the Nobel Prize for Medicine, at his home in North Andover, Massachusetts October 5, 2015. Three scientists from Japan, China and Ireland whose discoveries led to the development of potent new drugs against parasitic diseases such as malaria and elephantiasis won the Nobel Prize for Medicine on Monday. Irish-born William Campbell and Japan's Satoshi Omura won half of the prize for discovering avermectin, a derivative of which has been used to treat hundreds of millions of people with river blindness and lymphatic filariasis, or elephantiasis. REUTERS/Brian Snyder
NOBEL-PRIZE/MEDICINE
RTS331J
October 05, 2015
William C. Campbell, a parasitologist and RISE Associate with Drew University, poses near a collection...
NORTH ANDOVER, UNITED STATES
William C. Campbell reacts shortly after learning that he was a co-winner of the Nobel Prize for Medicine,...
William C. Campbell, a parasitologist and RISE Associate with Drew University, poses near a collection of microscopes shortly after learning that he was a co-winner of the Nobel Prize for Medicine, at his home in North Andover, Massachusetts October 5, 2015. Three scientists from Japan, China and Ireland whose discoveries led to the development of potent new drugs against parasitic diseases such as malaria and elephantiasis won the Nobel Prize for Medicine on Monday. Irish-born William Campbell and Japan's Satoshi Omura won half of the prize for discovering avermectin, a derivative of which has been used to treat hundreds of millions of people with river blindness and lymphatic filariasis, or elephantiasis. REUTERS/Brian Snyder
NOBEL-PRIZE/MEDICINE
RTS3310
October 05, 2015
William C. Campbell, a parasitologist and RISE Associate with Drew University, poses near a collection...
NORTH ANDOVER, UNITED STATES
William C. Campbell reacts shortly after learning that he was a co-winner of the Nobel Prize for Medicine,...
William C. Campbell, a parasitologist and RISE Associate with Drew University, poses near a collection of microscopes shortly after learning that he was a co-winner of the Nobel Prize for Medicine, at his home in North Andover, Massachusetts October 5, 2015. Three scientists from Japan, China and Ireland whose discoveries led to the development of potent new drugs against parasitic diseases such as malaria and elephantiasis won the Nobel Prize for Medicine on Monday. Irish-born William Campbell and Japan's Satoshi Omura won half of the prize for discovering avermectin, a derivative of which has been used to treat hundreds of millions of people with river blindness and lymphatic filariasis, or elephantiasis. REUTERS/Brian Snyder
PAKISTAN-CRIME/FORENSICS
RTR4MUQ3
January 25, 2015
A forensic scientist compares bullets at the ballistics department at Punjab Forensic Science Agency...
Lahore, Pakistan
A forensic scientist compares bullets at the ballistics department at Punjab Forensic Science Agency...
A forensic scientist compares bullets at the ballistics department at Punjab Forensic Science Agency in Lahore January 13, 2015. As one of America's top forensic scientists, Mohammad Tahir uncovered evidence that helped jail boxer Mike Tyson for rape, convict serial killer John Wayne Gacy and clear doctor Sam Sheppard of murdering his wife. Then Tahir took on his toughest assignment yet - applying his skills in Pakistan, a poor nation of 180 million people beset by crime and militancy. Picture taken January 13, 2015. REUTERS/Zohra Bensemra (PAKISTAN - Tags: SCIENCE TECHNOLOGY CRIME LAW)
NOBEL-PRIZE/CHEMISTRY
RTR49E2E
October 08, 2014
German scientist and Nobel prize winner Stefan Hell poses with a nanoscale microscope at the Max Planck...
Goettingen, Germany
Chemistry Nobel prize winner Hell poses with a nanoscale microscope in Goettingen
German scientist and Nobel prize winner Stefan Hell poses with a nanoscale microscope at the Max Planck Institute for Biophysical Chemistry in Goettingen October 8, 2014. U.S. citizens Eric Betzig and William Moerner and Germany's Stefan Hell won the 2014 Nobel Prize for Chemistry on Wednesday for smashing the size barrier in optical microscopes, allowing researchers to see individual molecules inside living cells. REUTERS/Kai Pfaffenbach (GERMANY - Tags: SCIENCE TECHNOLOGY TPX IMAGES OF THE DAY)
GERMANY-MILITARY/
RTR493U7
October 06, 2014
Rolf Wirtgen, director of the Scientific Collection of Defence Engineering Specimens of the Federal Office...
Koblenz, Germany
A Boxer, a German-Dutch multirole armoured fighting vehicle is seen at the Scientific Collection of Defence...
Rolf Wirtgen, director of the Scientific Collection of Defence Engineering Specimens of the Federal Office of Equipment, Information Technology and In-Service Support in Koblenz (BAAINBw - Bundesamt fuer 'Ausruestung, Informationstechnik und Nutzung der Bundeswehr' ) stands in front of a Boxer, a German-Dutch multirole armoured fighting vehicle at the Bundeswehr collection in Koblenz October 6, 2014. The Bundeswehr spent some 850 million Deutsche Mark (about 435 million Euro) in the years 1973-1975 on the VT 1-2 but did not realize the project due to substantial problems during tactical missions and in the field. A report by KPMG commissioned by German Defence Minister Von der Leyen shortly after she took office in late 2013, identified 140 problems and risks facing key arms projects. Ursula von der Leyen acknowledged in recent weeks that some of Germany's equipment is in such condition that is unable to meet its NATO commitments, although she stressed Berlin could still play a strong role in foreign military missions. REUTERS/Wolfgang Rattay (GERMANY - Tags: MILITARY POLITICS)
GERMANY-MILITARY/
RTR493TL
October 06, 2014
A Boxer, a German-Dutch multi-role armoured fighting vehicle is seen at the Scientific Collection of...
Koblenz, Germany
A Boxer, a German-Dutch multi-role armoured fighting vehicle is seen at the Scientific Collection of...
A Boxer, a German-Dutch multi-role armoured fighting vehicle is seen at the Scientific Collection of Defense Engineering Specimens of the Federal Office of Equipment, Information Technology and In-Service Support in Koblenz (BAAINBw - Bundesamt fuer 'Ausruestung, Informationstechnik und Nutzung der Bundeswehr' ) at the Bundeswehr collection in Koblenz October 6, 2014. A report by KPMG commissioned by German Defence Minister Von der Leyen shortly after she took office in late 2013, identified 140 problems and risks facing key arms projects. Ursula von der Leyen acknowledged in recent weeks that some of Germany's equipment is in such condition that is unable to meet its NATO commitments, although she stressed Berlin could still play a strong role in foreign military missions. REUTERS/Wolfgang Rattay (GERMANY - Tags: MILITARY POLITICS)
GERMANY-MILITARY/
RTR493T1
October 06, 2014
Rolf Wirtgen, director of the Scientific Collection of Defence Engineering Specimens of the Federal Office...
Koblenz, Germany
A twin-barrel prototype tank is seen at the Scientific Collection of Defence Engineering Specimens of...
Rolf Wirtgen, director of the Scientific Collection of Defence Engineering Specimens of the Federal Office of Equipment, Information Technology and In-Service Support in Koblenz (BAAINBw - Bundesamt fuer 'Ausruestung, Informationstechnik und Nutzung der Bundeswehr' ) walks past a prototype VT 1-2 twin-barrel casemate tank at the Bundeswehr collection in Koblenz October 6, 2014. The Bundeswehr spent some 850 million Deutsche Mark (about 435 million Euro) in the years 1973-1975 on the VT 1-2 but did not realize the project due to substantial problems during tactical missions and in the field. A report by KPMG commissioned by German Defence Minister Von der Leyen shortly after she took office in late 2013, identified 140 problems and risks facing key arms projects. Ursula von der Leyen acknowledged in recent weeks that some of Germany's equipment is in such condition that is unable to meet its NATO commitments, although she stressed Berlin could still play a strong role in foreign military missions. REUTERS/Wolfgang Rattay (GERMANY - Tags: MILITARY POLITICS)
HEALTH-EBOLA/GERMANY-COMPANY
RTR42FWN
August 14, 2014
A laboratory technican of the company Icon Genetics prepares proteines from Tobacco plants (Nicotiana...
Berlin, Germany
A laboratory technican of the company Icon Genetics prepares proteines from Tobacco plants (Nicotiana...
A laboratory technican of the company Icon Genetics prepares proteines from Tobacco plants (Nicotiana benthamiana) for weighing in a laboratory in Halle, August 14, 2014. Icon Genetics develop a technology to mass produce Ebola vaccine with the help of tobacco plants. REUTERS/Axel Schmidt (GERMANY - Tags: HEALTH SCIENCE TECHNOLOGY)
HEALTH-EBOLA/GERMANY-COMPANY
RTR42FWM
August 14, 2014
Laboratory technicans of the company Icon Genetics prepare proteines from Tobacco plants (Nicotiana benthamiana)...
Berlin, Germany
Laboratory technicans of the company Icon Genetics prepare proteines from Tobacco plants (Nicotiana benthamiana)...
Laboratory technicans of the company Icon Genetics prepare proteines from Tobacco plants (Nicotiana benthamiana) for weighing in a laboratory in Halle, August 14, 2014. Icon Genetics develop a technology to mass produce Ebola vaccine with the help of tobacco plants. REUTERS/Axel Schmidt (GERMANY - Tags: HEALTH SCIENCE TECHNOLOGY)
HEALTH-EBOLA/
RTR41ZI5
August 11, 2014
Doctor for tropical medicine Florian Steiner wears a protective suit as looks through a microscope at...
Berlin, Germany
Physician looks through microscope at quarantine station for patients with infectious diseases in Berlin...
Doctor for tropical medicine Florian Steiner wears a protective suit as looks through a microscope at the quarantine station for patients with infectious diseases at the Charite hospital in Berlin August 11, 2014. The isolation ward at the Charite is one of several centres in Germany equipped to treat patients suffering from ebola and other highly infectious diseases, the clinic's doctor for tropical medicine Florian Steiner said. Ebola is one of the deadliest diseases known to humanity. It has no proven cure and there is no vaccine to prevent infection. The most effective treatment involves alleviating symptoms that include fever, vomiting and diarrhoea. The rigorous use of quarantine is needed to prevent its spread, as well as high standards of hygiene for anyone who might come into contact with the disease.REUTERS/Thomas Peter (GERMANY - Tags: HEALTH)
HEALTH-EBOLA/
RTR41ZI1
August 11, 2014
Doctor for tropical medicine Florian Steiner demonstrates the testing of a blood sample at the quarantine...
Berlin, Germany
Physician demonstrates testing of blood sample at quarantine station for patients with infectious diseases...
Doctor for tropical medicine Florian Steiner demonstrates the testing of a blood sample at the quarantine station for patients with infectious diseases at the Charite hospital in Berlin August 11, 2014. The isolation ward at the Charite is one of several centres in Germany equipped to treat patients suffering from ebola and other highly infectious diseases, the clinic's doctor for tropical medicine Florian Steiner said. Ebola is one of the deadliest diseases known to humanity. It has no proven cure and there is no vaccine to prevent infection. The most effective treatment involves alleviating symptoms that include fever, vomiting and diarrhoea. The rigorous use of quarantine is needed to prevent its spread, as well as high standards of hygiene for anyone who might come into contact with the disease. REUTERS/Thomas Peter (GERMANY - Tags: HEALTH)
PHILIPPINES/
RTR3VM0B
June 25, 2014
A Philippine Drug Enforcement Agency (PDEA) chemist tests confiscated marijuana leaves during the destruction...
Cavite, Philippines
A PDEA chemist tests confiscated marijuana leaves during the destruction of confiscated illegal drugs...
A Philippine Drug Enforcement Agency (PDEA) chemist tests confiscated marijuana leaves during the destruction of confiscated illegal drugs in Trece Martires town, Cavite, south of Manila June 25, 2014. A total of 386.08 kilograms of assorted pieces of drug evidence composed of methamphetamine hydrochloride, locally known as "shabu", ephedrine, cocaine, marijuana, ecstasy, valium, oxycodone and expired medicines worth 637.85 million pesos ($14.5 million) were destroyed on Wednesday, according to a PDEA statement. REUTERS/Romeo Ranoco (PHILIPPINES - Tags: CRIME LAW DRUGS SOCIETY)
HUNGARY-BEE/
RTR3KF96
April 08, 2014
Experts inspect the wings of a dead bee to determine its breed at the Apiarian Research Centre in Godollo,...
GODOLLO, Hungary
Experts inspect the wings of a dead bee to determine its breed at the Apiarian Research Centre in Godollo...
Experts inspect the wings of a dead bee to determine its breed at the Apiarian Research Centre in Godollo, 25 km east of the Hungarian capital Budapest, on June 5, 2013. Picture taken July 5, 2013. REUTERS/Laszlo Balogh (HUNGARY - Tags: ENVIRONMENT ANIMALS)
WATCHES-CRAFTSMANSHIP/
RTX17ZVC
January 29, 2014
Enameller Anita Porchet works on a personal project in her workshop in Corcelles-le-Jorat in western...
CORCELLES-LE-JORAT, Switzerland
Enameller Porchet works on a personal project in her workshop in Corcelle-le-Jorat in western Switzerland...
Enameller Anita Porchet works on a personal project in her workshop in Corcelles-le-Jorat in western Switzerland January 29, 2014. Porchet has a skill that Swiss watchmakers can't afford to do without. As an enamel painter, she decorates watches for the likes of Patek Philippe and Vacheron Constantin which can sell for hundreds of thousands of dollars. But the industry is facing a severe shortage of craftsmen and women who have mastered the techniques of enamel painting, marquetry and engine-turning - at a time when there is growing demand for high-end handmade watches.To match WATCHES-CRAFTSMANSHIP/ REUTERS/Denis Balibouse (SWITZERLAND - Tags: SOCIETY BUSINESS)
BOLIVIA/
RTX168D7
December 07, 2013
Lemon oil is tested at lab in Cuatro Canadas, some 110 km (68 miles) from Santa Cruz December 6, 2013....
CUATRO CANADAS, Bolivia
Lemon oil is tested at lab in Cuatro Canadas
Lemon oil is tested at lab in Cuatro Canadas, some 110 km (68 miles) from Santa Cruz December 6, 2013. REUTERS/David Mercado (BOLIVIA - Tags: AGRICULTURE)
WATCHES-TAG-HEUER/
RTX15188
November 05, 2013
Watchmakers work at Tag Heuer production in their new watch factory in Chevenez November 5, 2013. Swiss...
CHEVENEZ, Switzerland
Watchmakers work at Tag Heuer production in their new watch factory in Chevenez
Watchmakers work at Tag Heuer production in their new watch factory in Chevenez November 5, 2013. Swiss watch brand TAG Heuer expects single-digit sales growth this year and is aiming to outperform market growth estimated at about 5 percent in 2014, its head told Reuters on Tuesday. REUTERS/Ruben Sprich (SWITZERLAND - Tags: BUSINESS)
INDIA/
RTX146F7
October 10, 2013
Doctor Harsha Bhadarka, an embryologist, works inside a lab belonging to Akanksha IVF center in Anand...
ANAND, India
Doctor Bhadarka, an embryologist, works inside a lab belonging to Akanksha IVF center in Anand town
Doctor Harsha Bhadarka, an embryologist, works inside a lab belonging to Akanksha IVF center in Anand town, about 70 km (44 miles) south from the western Indian city of Ahmedabad August 24, 2013. REUTERS/Mansi Thapliyal (INDIA - Tags: HEALTH SOCIETY)
CANCER-DRUGS/
RTX1405J
September 26, 2013
Sample analysis tubes are seen in a lab at the Institute of Cancer Research in Sutton, July 15, 2013....
Sutton, United Kingdom
Sample analysis tubes are seen in a lab at the Institute of Cancer Research in Sutton
Sample analysis tubes are seen in a lab at the Institute of Cancer Research in Sutton, July 15, 2013. Picture taken July 15, 2013. To match Insight CANCER-DRUGS/ REUTERS/Stefan Wermuth (BRITAIN - Tags: HEALTH SCIENCE TECHNOLOGY)
Sort by
Display
Items per page
Page
of 5